The role of NPY in hypothalamic mediated food intake

Frontiers in Neuroendocrinology

Volumn 32, Issue 4, 2011, Pages 398-415

  Mercer, Rebecca E ^a   Chee, Melissa J S ^b   Colmers, William F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Animal models; Compensation; Energy balance; Food intake; Hypothalamus; Integration; Neuropeptide Y; Redundancy

Indexed keywords

NEUROPEPTIDE; NEUROPEPTIDE Y;

ENERGY BALANCE; FOOD INTAKE; GENE INTERACTION; GENETIC MANIPULATION; GERM LINE; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APPETITE REGULATION; EATING; ENERGY METABOLISM; GENETIC TECHNIQUES; HUMANS; HYPOTHALAMUS; MODELS, BIOLOGICAL; NEUROPEPTIDE Y;

EID: 80053094974     PISSN: 00913022     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.yfrne.2011.06.001     Document Type: Review

References (324)

1. Abbott C.R., Small C.J., Kennedy A.R., Neary N.M., Sajedi A., Ghatei M.A., Bloom S.R. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res. 2005, 1-2:139-144.
2. Acuna-Goycolea C., Tamamaki N., Yanagawa Y., Obata K., van den Pol A.N. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J. Neurosci. 2005, 32:7406-7419.
3. Ahima R.S., Lazar M.A. Adipokines and the peripheral and neural control of energy balance. Mol. Endocrinol. 2008, 5:1023-1031.
4. Air E.L., Benoit S.C., Blake Smith K.A., Clegg D.J., Woods S.C. Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol. Biochem. Behav. 2002, 1-2:423-429.
5. Alexander G.M., Rogan S.C., Abbas A.I., Armbruster B.N., Pei Y., Allen J.A., Nonneman R.J., Hartmann J., Moy S.S., Nicolelis M.A., McNamara J.O., Roth B.L. Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 2009, 1:27-39.
6. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., Polak J.M. Neuropeptide Y distribution in the rat brain. Science 1983, 4613:877-879.
7. Ammar D.A., Eadie D.M., Wong D.J., Ma Y.Y., Kolakowski Jr L.F., Yang-Feng T.L., Thompson D.A. Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene. Genomics 1996, 3:392-398.
8. Anand B.K., Brobeck J.R. Hypothalamic control of food intake in rats and cats. Yale J. Biol. Med. 1951, 24:123.
9. Ando M., Sato N., Nagase T., Nagai K., Ishikawa S., Takahashi H., Ohtake N., Ito J., Hirayama M., Mitobe Y., Iwaasa H., Gomori A., Matsushita H., Tadano K., Fujino N., Tanaka S., Ohe T., Ishihara A., Kanatani A., Fukami T. Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor. Bioorg. Med. Chem. 2009, 16:6106-6122.
10. Antal-Zimanyi I., Bruce M.A., Leboulluec K.L., Iben L.G., Mattson G.K., McGovern R.T., Hogan J.B., Leahy C.L., Flowers S.C., Stanley J.A., Ortiz A.A., Poindexter G.S. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist. Eur. J. Pharmacol. 2008, 1-3:224-232.
11. Aponte Y., Atasoy D., Sternson S.M. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat. Neurosci. 2011, 3:351-355.
12. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 2001, 10:4753-4758.
13. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Niijima A., Fujino M.A., Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001, 2:337-345.
14. Backberg M., Collin M., Ovesjo M.L., Meister B. Chemical coding of GABA(B) receptor-immunoreactive neurones in hypothalamic regions regulating body weight. J. Neuroendocrinol. 2003, 1:1-14.
15. Bai F.L., Yamano M., Shiotani Y., Emson P.C., Smith A.D., Powell J.F., Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 1985, 1:172-175.
16. Balasubramaniam A., Joshi R., Su C., Friend L.A., James J.H. Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists. Peptides 2007, 2:235-240.
17. Balasubramaniam A., Sheriff S., Rigel D.F., Fischer J.E. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes. Peptides 1990, 3:545-550.
18. Baldock P.A., Allison S.J., Lundberg P., Lee N.J., Slack K., Lin E.J., Enriquez R.F., McDonald M.M., Zhang L., During M.J., Little D.G., Eisman J.A., Gardiner E.M., Yulyaningsih E., Lin S., Sainsbury A., Herzog H. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J. Biol. Chem. 2007, 26:19092-19102.
19. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., McCaleb M.L. Behavioral characterization of neuropeptide Y knockout mice. Brain Res. 2000, 1:79-87.
20. Baskin D.G., Breininger J.F., Bonigut S., Miller M.A. Leptin binding in the arcuate nucleus is increased during fasting. Brain Res. 1999, 1-2:154-158.
21. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., Cone R.D., Bloom S.R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 6898:650-654.
22. Beck B., Richy S., Dimitrov T., Stricker-Krongrad A. Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats. Biochem. Biophys. Res. Commun. 2001, 3:518-523.
23. Beck B., Stricker-Krongrad A., Nicolas J.P., Burlet C. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Int. J. Obes. Relat. Metab. Disord. 1992, 4:295-302.
24. Berg A.H., Combs T.P., Scherer P.E. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Trends Endocrinol. Metab. 2002, 2:84-89.
25. Bergonzelli G.E., Pralong F.P., Glauser M., Cavadas C., Grouzmann E., Gaillard R.C. Interplay between galanin and leptin in the hypothalamic control of feeding via corticotropin-releasing hormone and neuropeptide Y. Diabetes 2001, 12:2666-2672.
26. Bernardis L.L. Participation of the dorsomedial hypothalamic nucleus in the " feeding center" and water intake circuitry of the weanling rat. J. Neurovisc. Relat. 1970, 4:387-398.
27. Bi S., Ladenheim E.E., Schwartz G.J., Moran T.H. A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 1:R254-R260.
28. Billes S.K., Cowley M.A. Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice. Neuropsychopharmacology 2007, 4:822-834.
29. Blomqvist A.G., Soderberg C., Lundell I., Milner R.J., Larhammar D. Strong evolutionary conservation of neuropeptide Y: sequences of chicken, goldfish, and Torpedo marmorata DNA clones. Proc. Natl. Acad. Sci. USA 1992, 6:2350-2354.
30. Bouali S.M., Fournier A., St.-Pierre S., Jolicoeur F.B. Effects of NPY and NPY2-36 on body temperature and food intake following administration into hypothalamic nuclei. Brain Res. Bull. 1995, 2:131-135.
31. Boughton C.K., Patterson M., Bewick G.A., Tadross J.A., Gardiner J.V., Beale K.E., Chaudery F., Hunter G., Busbridge M., Leavy E.M., Ghatei M.A., Bloom S.R., Murphy K.G. Alarin stimulates food intake and gonadotrophin release in male rats. Br. J. Pharmacol. 2010, 3:601-613.
32. Bouret S.G., Draper S.J., Simerly R.B. Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J. Neurosci. 2004, 11:2797-2805.
33. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 2005, 9:1263-1268.
34. Brady L.S., Smith M.A., Gold P.W., Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 1990, 5:441-447.
35. Brief D.J., Davis J.D. Reduction of food intake and body weight by chronic intraventricular insulin infusion. Brain Res. Bull. 1984, 5:571-575.
36. Briggs D.I., Enriori P.J., Lemus M.B., Cowley M.A., Andrews Z.B. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 2010, 10:4745-4755.
37. BROBECK J.R. Mechanism of the development of obesity in animals with hypothalamic lesions. Physiol. Rev. 1946, 4:541-559.
38. Broberger C., De Lecea L., Sutcliffe J.G., Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol. 1998, 4:460-474.
39. Broberger C., Johansen J., Johansson C., Schalling M., Hokfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. USA 1998, 25:15043-15048.
40. Broberger C., Landry M., Wong H., Walsh J.N., Hokfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 1997, 6:393-408.
41. Bromee T., Sjodin P., Fredriksson R., Boswell T., Larsson T.A., Salaneck E., Zoorob R., Mohell N., Larhammar D. Neuropeptide Y-family receptors Y6 and Y7 in chicken. Cloning, pharmacological characterization, tissue distribution and conserved synteny with human chromosome region. FEBS J. 2006, 9:2048-2063.
42. Buchanan J.B., Johnson R.W. Regulation of food intake by inflammatory cytokines in the brain. Neuroendocrinology 2007, 3:183-190.
43. Caberlotto L., Fuxe K., Hurd Y.L. Characterization of NPY mRNA-expressing cells in the human bra: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J. Chem. Neuroanat. 2000, 3-4:327-337.
44. Cabrele C., Langer M., Bader R., Wieland H.A., Doods H.N., Zerbe O., Beck-Sickinger A.G. The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J. Biol. Chem. 2000, 46:36043-36048.
45. Campfield L.A., Smith F.J., Guisez Y., Devos R., Burn P. Recombinant mouse OB prote: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 5223:546-549.
46. Chance W.T., Balasubramaniam A., Zhang F.S., Wimalawansa S.J., Fischer J.E. Anorexia following the intrahypothalamic administration of amylin. Brain Res. 1991, 2:352-354.
47. Chao P.T., Yang L., Aja S., Moran T.H., Bi S. Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity. Cell. Metab. 2011, 5:573-583.
48. Chee M.J., Colmers W.F. Y eat? Nutrition 2008, 9:869-877.
49. Chee M.J., Myers Jr M.G., Price C.J., Colmers W.F. Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus. J. Neurosci. 2010, 9:3380-3390.
50. Chen H.Y., Trumbauer M.E., Chen A.S., Weingarth D.T., Adams J.R., Frazier E.G., Shen Z., Marsh D.J., Feighner S.D., Guan X.M., Ye Z., Nargund R.P., Smith R.G., Van der Ploeg L.H., Howard A.D., MacNeil D.J., Qian S. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004, 6:2607-2612.
51. Chen P., Smith M.S. Suckling-induced activation of neuronal input to the dorsomedial nucleus of the hypothalamus: possible candidates for mediating the activation of DMH neuropeptide Y neurons during lactation. Brain Res. 2003, 1-2:11-20.
52. Chen X., DiMaggio D.A., Han S.P., Westfall T.C. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors. Am. J. Physiol. 1997, 2(4 Pt):H1737-H1744.
53. Cheng X., Broberger C., Tong Y., Yongtao X., Ju G., Zhang X., Hokfelt T. Regulation of expression of neuropeptide Y Y1 and Y2 receptors in the arcuate nucleus of fasted rats. Brain Res. 1998, 1:89-96.
54. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 1985, 4:1159-1181.
55. Clark J.T., Kalra P.S., Kalra S.P. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 1985, 6:2435-2442.
56. Collin M., Backberg M., Ovesjo M.L., Fisone G., Edwards R.H., Fujiyama F., Meister B. Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. Eur. J. Neurosci. 2003, 5:1265-1278.
57. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 2005, 5:571-578.
58. Coope A., Milanski M., Araujo E.P., Tambascia M., Saad M.J., Geloneze B., Velloso L.A. AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus. FEBS Lett. 2008, 10:1471-1476.
59. Cowley M.A., Pronchuk N., Fan W., Dinulescu D.M., Colmers W.F., Cone R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 1999, 1:155-163.
60. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L., Cone R.D., Low M.J. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 6836:480-484.
61. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., Garcia-Segura L.M., Nillni E.A., Mendez P., Low M.J., Sotonyi P., Friedman J.M., Liu H., Pinto S., Colmers W.F., Cone R.D., Horvath T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 4:649-661.
62. Crawley J.N., Austin M.C., Fiske S.M., Martin B., Consolo S., Berthold M., Langel U., Fisone G., Bartfai T. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J. Neurosci. 1990, 11:3695-3700.
63. Criscione L., Rigollier P., Batzl-Hartmann C., Rueger H., Stricker-Krongrad A., Wyss P., Brunner L., Whitebread S., Yamaguchi Y., Gerald C., Heurich R.O., Walker M.W., Chiesi M., Schilling W., Hofbauer K.G., Levens N. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. J. Clin. Invest. 1998, 12:2136-2145.
64. Cunningham M.J., Scarlett J.M., Steiner R.A. Cloning and distribution of galanin-like peptide mRNA in the hypothalamus and pituitary of the macaque. Endocrinology 2002, 3:755-763.
65. Currie P.J., Coscina D.V. Regional hypothalamic differences in neuropeptide Y-induced feeding and energy substrate utilization. Brain Res. 1996, 1-2:238-242.
66. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Matsukura S., Kangawa K., Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 11:4255-4261.
67. Davidowa H., Li Y., Plagemann A. Differential response to NPY of PVH and dopamine-responsive VMH neurons in overweight rats. Neuroreport 2002, 12:1523-1527.
68. Davidowa H., Plagemann A. Insulin resistance of hypothalamic arcuate neurons in neonatally overfed rats. Neuroreport 2007, 5:521-524.
69. Davidowa H., Ziska T., Plagemann A. Arcuate neurons of overweight rats differ in their responses to amylin from controls. Neuroreport 2004, 18:2801-2805.
70. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 1998, 1:322-327.
71. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system - II. Immunohistochemical analysis. Neuroscience 1986, 3:545-618.
72. DeCarr L.B., Buckholz T.M., Milardo L.F., Mays M.R., Ortiz A., Lumb K.J. A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice. Bioorg. Med. Chem. Lett. 2007, 7:1916-1919.
73. Degen L., Oesch S., Casanova M., Graf S., Ketterer S., Drewe J., Beglinger C. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 2005, 5:1430-1436.
74. Della Zuana O., Sadlo M., Germain M., Feletou M., Chamorro S., Tisserand F., de Montrion C., Boivin J.F., Duhault J., Boutin J.A., Levens N. Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade. Int. J. Obes. Relat. Metab. Disord. 2001, 1:84-94.
75. Della-Zuana O., Presse F., Ortola C., Duhault J., Nahon J.L., Levens N. Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats. Int. J. Obes. Relat. Metab. Disord. 2002, 10:1289-1295.
76. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 6830:822-825.
77. Dodd G.T., Stark J.A., McKie S., Williams S.R., Luckman S.M. Central cannabinoid signaling mediating food intake: a pharmacological-challenge magnetic resonance imaging and functional histology study in rat. Neuroscience 2009, 4:1192-1200.
78. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W., Rudolf K. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol. 1999, 2-3:R3-5.
79. Doods H.N., Wieland H.A., Engel W., Eberlein W., Willim K.D., Entzeroth M., Wienen W., Rudolf K. BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul. Pept. 1996, 1:71-77.
80. Dryden S., Pickavance L., Frankish H.M., Williams G. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 1995, 2:185-188.
81. Dube M.G., Horvath T.L., Kalra P.S., Kalra S.P. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats. Peptides 2000, 10:1557-1560.
82. Dube M.G., Sahu A., Kalra P.S., Kalra S.P. Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. Endocrinology 1992, 2:684-688.
83. Dumont Y., Cadieux A., Doods H., Pheng L.H., Abounader R., Hamel E., Jacques D., Regoli D., Quirion R. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br. J. Pharmacol. 2000, 6:1075-1088.
84. Dumont Y., Jacques D., Bouchard P., Quirion R. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J. Comp. Neurol. 1998, 3:372-384.
85. Durkin M.M., Walker M.W., Smith K.E., Gustafson E.L., Gerald C., Branchek T.A. Expression of a novel neuropeptide Y receptor subtype involved in food intake: an in situ hybridization study of Y5 mRNA distribution in rat brain. Exp. Neurol. 2000, 1:90-100.
86. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J., Tatro J.B., Hoffman G.E., Ollmann M.M., Barsh G.S., Sakurai T., Yanagisawa M., Elmquist J.K. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 1998, 4:442-459.
87. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 1998, 4:535-547.
88. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996, 6581:415-421.
89. Erickson J.C., Hollopeter G., Palmiter R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996, 5293:1704-1707.
90. Erondu N., Addy C., Lu K., Mallick M., Musser B., Gantz I., Proietto J., Astrup A., Toubro S., Rissannen A.M., Tonstad S., Haynes W.G., Gottesdiener K.M., Kaufman K.D., Amatruda J.M., Heymsfield S.B. NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine. Obesity 2007, (Silver Spring):2027-2042.
91. Erondu N., Gantz I., Musser B., Suryawanshi S., Mallick M., Addy C., Cote J., Bray G., Fujioka K., Bays H., Hollander P., Sanabria-Bohorquez S.M., Eng W., Langstrom B., Hargreaves R.J., Burns H.D., Kanatani A., Fukami T., MacNeil D.J., Gottesdiener K.M., Amatruda J.M., Kaufman K.D., Heymsfield S.B. Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell. Metab. 2006, 4:275-282.
92. Erondu N., Wadden T., Gantz I., Musser B., Nguyen A.M., Bays H., Bray G., O'Neil P.M., Basdevant A., Kaufman K.D., Heymsfield S.B., Amatruda J.M. Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss. Obesity 2007, (Silver Spring):895-905.
93. Farooqi I.S., Keogh J.M., Kamath S., Jones S., Gibson W.T., Trussell R., Jebb S.A., Lip G.Y., O'Rahilly S. Partial leptin deficiency and human adiposity. Nature 2001, 6859:34-35.
94. Fekete C., Sarkar S., Rand W.M., Harney J.W., Emerson C.H., Bianco A.C., Beck-Sickinger A., Lechan R.M. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. Endocrinology 2002, 12:4513-4519.
95. Fetissov S.O., Byrne L.C., Hassani H., Ernfors P., Hokfelt T. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus. J. Comp. Neurol. 2004, 3:256-265.
96. Flood J.F., Morley J.E. Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation. Peptides 1989, 5:963-966.
97. Florant G.L., Singer L., Scheurink A.J., Park C.R., Richardson R.D., Woods S.C. Intraventricular insulin reduces food intake and body weight of marmots during the summer feeding period. Physiol. Behav. 1991, 2:335-338.
98. Fong T.M., Mao C., MacNeil T., Kalyani R., Smith T., Weinberg D., Tota M.R., Van der Ploeg L.H. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem. Biophys. Res. Commun. 1997, 3:629-631.
99. Fredriksson R., Larson E.T., Yan Y.L., Postlethwait J.H., Larhammar D. Novel neuropeptide Y Y2-like receptor subtype in zebrafish and frogs supports early vertebrate chromosome duplications. J. Mol. Evol. 2004, 1:106-114.
100. Fu L.Y., Acuna-Goycolea C., van den Pol A.N. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci. 2004, 40:8741-8751.
101. Galas L., Tonon M.C., Beaujean D., Fredriksson R., Larhammar D., Lihrmann I., Jegou S., Fournier A., Chartrel N., Vaudry H. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells. Endocrinology 2002, 5:1686-1694.
102. Gamber K.M., Macarthur H., Westfall T.C. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 2005, 5:646-652.
103. Gardiner J.V., Kong W.M., Ward H., Murphy K.G., Dhillo W.S., Bloom S.R. AAV mediated expression of anti-sense neuropeptide Y cRNA in the arcuate nucleus of rats results in decreased weight gain and food intake. Biochem. Biophys. Res. Commun. 2005, 4:1088-1093.
104. Gehlert D.R., Beavers L.S., Johnson D., Gackenheimer S.L., Schober D.A., Gadski R.A. Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol. Pharmacol. 1996, 2:224-228.
105. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996, 6587:168-171.
106. Gerald C., Walker M.W., Vaysse P.J., He C., Branchek T.A., Weinshank R.L. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J. Biol. Chem. 1995, 45:26758-26761.
107. Ghamari-Langroudi M., Colmers W.F., Cone R.D. PYY3-36 inhibits the action potential firing activity of POMC neurons of arcuate nucleus through postsynaptic Y2 receptors. Cell. Metab. 2005, 3:191-199.
108. Ghamari-Langroudi M., Srisai D., Cone R.D. Multinodal regulation of the arcuate/paraventricular nucleus circuit by leptin. Proc. Natl. Acad. Sci. USA 2011, 1:355-360.
109. Giesbrecht C.J., Mackay J.P., Silveira H.B., Urban J.H., Colmers W.F. Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J. Neurosci. 2010, 50:16970-16982.
110. Grove K.L., Allen S., Grayson B.E., Smith M.S. Postnatal development of the hypothalamic neuropeptide Y system. Neuroscience 2003, 2:393-406.
111. Grove K.L., Brogan R.S., Smith M.S. Novel expression of neuropeptide Y (NPY) mRNA in hypothalamic regions during development: region-specific effects of maternal deprivation on NPY and Agouti-related protein mRNA. Endocrinology 2001, 11:4771-4776.
112. Grove K.L., Smith M.S. Ontogeny of the hypothalamic neuropeptide Y system. Physiol. Behav. 2003, 1:47-63.
113. Grundemar L., Wahlestedt C., Reis D.J. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. J. Pharmacol. Exp. Ther. 1991, 2:633-638.
114. Guan X.M., Yu H., Trumbauer M., Frazier E., Van der Ploeg L.H., Chen H. Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice. Neuroreport 1998, 15:3415-3419.
115. Guan X.M., Yu H., Van der Ploeg L.H. Evidence of altered hypothalamic pro-opiomelanocortin/neuropeptide Y mRNA expression in tubby mice. Brain Res. Mol. Brain Res. 1998, 2:273-279.
116. Guillod-Maximin E., Roy A.F., Vacher C.M., Aubourg A., Bailleux V., Lorsignol A., Penicaud L., Parquet M., Taouis M. Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J. Endocrinol. 2009, 1:93-105.
117. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., Branchek T.A. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Brain Res. Mol. Brain Res. 1997, 1-2:223-235.
118. Haga Y., Sakamoto T., Shibata T., Nonoshita K., Ishikawa M., Suga T., Takahashi H., Takahashi T., Takahashi H., Ando M., Murai T., Gomori A., Oda Z., Kitazawa H., Mitobe Y., Kanesaka M., Ohe T., Iwaasa H., Ishii Y., Ishihara A., Kanatani A., Fukami T. Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1'-c yclohexane]-4'-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist. Bioorg. Med. Chem. 2009, 19:6971-6982.
119. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 5223:543-546.
120. Harthoorn L.F., Sane A., Nethe M., Van Heerikhuize J.J. Multi-transcriptional profiling of melanin-concentrating hormone and orexin-containing neurons. Cell. Mol. Neurobiol. 2005, 8:1209-1223.
121. Heilig M., Vecsei L., Widerlov E. Opposite effects of centrally administered neuropeptide Y (NPY) on locomotor activity of spontaneously hypertensive (SH) and normal rats. Acta Physiol. Scand. 1989, 2:243-248.
122. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA 1992, 13:5794-5798.
123. Hetherington A.W., Ranson S.W. The relation of various hypothalamic lesions to adiposity in the rat. J. Comp. Neurol. 1942, 475-499.
124. Hetherington A.W., Ranson S.W. Hypothalamic lesions and adiposity in the rat. Anat. Rec. 1940, 149.
125. Hipskind P.A., Lobb K.L., Nixon J.A., Britton T.C., Bruns R.F., Catlow J., Dieckman-McGinty D.K., Gackenheimer S.L., Gitter B.D., Iyengar S., Schober D.A., Simmons R.M., Swanson S., Zarrinmayeh H., Zimmerman D.M., Gehlert D.R., Potent Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists. J. Med. Chem. 1997, 23:3712-3714.
126. Horvath T.L., Diano S., van den Pol A.N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 1999, 3:1072-1087.
127. Horvath T.L., Naftolin F., Leranth C., Sahu A., Kalra S.P. Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Endocrinology 1996, 7:3069-3078.
128. Howell O.W., Scharfman H.E., Herzog H., Sundstrom L.E., Beck-Sickinger A., Gray W.P. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J. Neurochem. 2003, 3:646-659.
129. Hoyda T.D., Smith P.M., Ferguson A.V. Adiponectin acts in the nucleus of the solitary tract to decrease blood pressure by modulating the excitability of neuropeptide Y neurons. Brain Res. 2009, 76-84.
130. Hu Y., Bloomquist B.T., Cornfield L.J., DeCarr L.B., Flores-Riveros J.R., Friedman L., Jiang P., Lewis-Higgins L., Sadlowski Y., Schaefer J., Velazquez N., McCaleb M.L. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem. 1996, 42:26315-26319.
131. Huang X.F., Han M., Storlien L.H. The level of NPY receptor mRNA expression in diet-induced obese and resistant mice. Brain Res. Mol. Brain Res. 2003, 1:21-28.
132. Ikeda H., West D.B., Pustek J.J., Figlewicz D.P., Greenwood M.R., Porte Jr D., Woods S.C. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 1986, 4:381-386.
133. Inui A., Okita M., Nakajima M., Momose K., Ueno N., Teranishi A., Miura M., Hirosue Y., Sano K., Sato M., Watanabe M., Sakai T., Watanabe T., Ishida K., Silver J., Baba S., Kasuga M. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. Proc. Assoc. Am. Physicians 1998, 3:171-182.
134. Ishihara A., Tanaka T., Kanatani A., Fukami T., Ihara M., Fukuroda T. A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats. Am. J. Physiol. 1998, 2(5 Pt):R1500-4.
135. Jacques D., Abdel-Samad D. Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium. Can. J. Physiol. Pharmacol. 2007, 1:43-53.
136. Jacques D., Tong Y., Dumont Y., Shen S.H., Quirion R. Expression of the neuropeptide Y Y1 receptor mRNA in the human bra: an in situ hybridization study. Neuroreport 1996, 5:1053-1056.
137. Jain M.R., Horvath T.L., Kalra P.S., Kalra S.P. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul. Pept. 2000, 1-3:19-24.
138. Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol. 2001, 6:1151-1154.
139. Jegou S., Boutelet I., Vaudry H. Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J. Neuroendocrinol. 2000, 6:501-505.
140. Jolicoeur F.B., Bouali S.M., Fournier A., St-Pierre S. Mapping of hypothalamic sites involved in the effects of NPY on body temperature and food intake. Brain Res. Bull. 1995, 2:125-129.
141. Jorgensen E.A., Knigge U., Watanabe T., Warberg J., Kjaer A. Histaminergic neurons are involved in the orexigenic effect of orexin-A. Neuroendocrinology 2005, 2:70-77.
142. Jureus A., Cunningham M.J., Li D., Johnson L.L., Krasnow S.M., Teklemichael D.N., Clifton D.K., Steiner R.A. Distribution and regulation of galanin-like peptide (GALP) in the hypothalamus of the mouse. Endocrinology 2001, 12:5140-5144.
143. Kaga T., Inui A., Okita M., Asakawa A., Ueno N., Kasuga M., Fujimiya M., Nishimura N., Dobashi R., Morimoto Y., Liu I.M., Cheng J.T. Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding. Diabetes 2001, 5:1206-1210.
144. Kahn S.E., D'Alessio D.A., Schwartz M.W., Fujimoto W.Y., Ensinck J.W., Taborsky G.J., Porte D. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 1990, 5:634-638.
145. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. USA 1991, 23:10931-10935.
146. Kalra S.P., Ueno N., Kalra P.S. Stimulation of appetite by ghrelin is regulated by leptin restraint: peripheral and central sites of action. J. Nutr. 2005, 5:1331-1335.
147. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001, 11:2438-2443.
148. Kanatani A., Hata M., Mashiko S., Ishihara A., Okamoto O., Haga Y., Ohe T., Kanno T., Murai N., Ishii Y., Fukuroda T., Fukami T., Ihara M. A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814. Mol. Pharmacol. 2001, 3:501-505.
149. Kanatani A., Kanno T., Ishihara A., Hata M., Sakuraba A., Tanaka T., Tsuchiya Y., Mase T., Fukuroda T., Fukami T., Ihara M. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability. Biochem. Biophys. Res. Commun. 1999, 1:88-91.
150. Kanatani A., Mashiko S., Murai N., Sugimoto N., Ito J., Fukuroda T., Fukami T., Morin N., MacNeil D.J., Van der Ploeg L.H., Saga Y., Nishimura S., Ihara M. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 2000, 3:1011-1016.
151. Kang L., Routh V.H., Kuzhikandathil E.V., Gaspers L.D., Levin B.E. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004, 3:549-559.
152. Kask A., Rago L., Harro J. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226. Br. J. Pharmacol. 1998, 7:1507-1515.
153. Kauffman A.S., Buenzle J., Fraley G.S., Rissman E.F. Effects of galanin-like peptide (GALP) on locomotion, reproduction, and body weight in female and male mice. Horm. Behav. 2005, 2:141-151.
154. Keen-Rhinehart E., Bartness T.J. NPY Y1 receptor is involved in ghrelin- and fasting-induced increases in foraging, food hoarding, and food intake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 4:R1728-37.
155. Kerr N.C., Holmes F.E., Wynick D. Galanin-like peptide (GALP) is expressed in rat hypothalamus and pituitary, but not in DRG. Neuroreport 2000, 17:3909-3913.
156. Kesterson R.A., Huszar D., Lynch C.A., Simerly R.B., Cone R.D. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol. Endocrinol. 1997, 5:630-637.
157. Kirkham T.C., Williams C.M., Fezza F., Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 2002, 4:550-557.
158. Klapstein G.J., Colmers W.F. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 1997, 3:1651-1661.
159. 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003, 4:948-956.
160. Kohno D., Nakata M., Maekawa F., Fujiwara K., Maejima Y., Kuramochi M., Shimazaki T., Okano H., Onaka T., Yada T. Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway. Endocrinology 2007, 5:2251-2263.
161. Kohno D., Sone H., Minokoshi Y., Yada T. Ghrelin raises [Ca2+]i via AMPK in hypothalamic arcuate nucleus NPY neurons. Biochem. Biophys. Res. Commun. 2008, 2:388-392.
162. Kokare D.M., Patole A.M., Carta A., Chopde C.T., Subhedar N.K. GABA(A) receptors mediate orexin-A induced stimulation of food intake. Neuropharmacology 2006, 1:16-24.
163. Kopp J., Xu Z.Q., Zhang X., Pedrazzini T., Herzog H., Kresse A., Wong H., Walsh J.H., Hokfelt T. Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 2002, 3:443-532.
164. Korner J., Savontaus E., Chua Jr S.C., Leibel R.L., Wardlaw S.L. Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus. J. Neuroendocrinol. 2001, 11:959-966.
165. Krashes M.J., Koda S., Ye C., Rogan S.C., Adams A.C., Cusher D.S., Maratos-Flier E., Roth B.L., Lowell B.B. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 2011.
166. Krasnow S.M., Fraley G.S., Schuh S.M., Baumgartner J.W., Clifton D.K., Steiner R.A. A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse. Endocrinology 2003, 3:813-822.
167. Kubota N., Yano W., Kubota T., Yamauchi T., Itoh S., Kumagai H., Kozono H., Takamoto I., Okamoto S., Shiuchi T., Suzuki R., Satoh H., Tsuchida A., Moroi M., Sugi K., Noda T., Ebinuma H., Ueta Y., Kondo T., Araki E., Ezaki O., Nagai R., Tobe K., Terauchi Y., Ueki K., Minokoshi Y., Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell. Metab. 2007, 1:55-68.
168. Kumarnsit E., Johnstone L.E., Leng G. Actions of neuropeptide Y and growth hormone secretagogues in the arcuate nucleus and ventromedial hypothalamic nucleus. Eur. J. Neurosci. 2003, 5:937-944.
169. Kuramochi M., Onaka T., Kohno D., Kato S., Yada T. Galanin-like peptide stimulates food intake via activation of neuropeptide Y neurons in the hypothalamic dorsomedial nucleus of the rat. Endocrinology 2006, 4:1744-1752.
170. Kushi A., Sasai H., Koizumi H., Takeda N., Yokoyama M., Nakamura M. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 1998, 26:15659-15664.
171. Kyrkouli S.E., Stanley B.G., Leibowitz S.F. Galan: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur. J. Pharmacol. 1986, 1:159-160.
172. Kyrkouli S.E., Stanley B.G., Seirafi R.D., Leibowitz S.F. Stimulation of feeding by galan: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 1990, 5:995-1001.
173. Lambert P.D., Wilding J.P., al-Dokhayel A.A., Bohuon C., Comoy E., Gilbey S.G., Bloom S.R. A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. Endocrinology 1993, 1:29-32.
174. Larhammar D. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul. Pept. 1996, 1:1-11.
175. Larhammar D., Salaneck E. Molecular evolution of NPY receptor subtypes. Neuropeptides 2004, 4:141-151.
176. Larm J.A., Gundlach A.L. Galanin-like peptide (GALP) mRNA expression is restricted to arcuate nucleus of hypothalamus in adult male rat brain. Neuroendocrinology 2000, 2:67-71.
177. Larsen P.J., Kristensen P. Distribution of neuropeptide Y receptor expression in the rat suprachiasmatic nucleus. Brain Res. Mol. Brain Res. 1998, 1:69-76.
178. Larsen P.J., Sheikh S.P., Jakobsen C.R., Schwartz T.W., Mikkelsen J.D. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur. J. Neurosci. 1993, 12:1622-1637.
179. Larsson S. On the hypothalamic organisation of the nervous mechanism regulating food intake. Acta Physiol. Scand. Suppl. 1954, 115:7-63.
180. Larsson T.A., Larson E.T., Fredriksson R., Conlon J.M., Larhammar D. Characterization of NPY receptor subtypes Y2 and Y7 in rainbow trout Oncorhynchus mykiss. Peptides 2006, 6:1320-1327.
181. Lawrence C.B., Baudoin F.M., Luckman S.M. Centrally administered galanin-like peptide modifies food intake in the rat: a comparison with galanin. J. Neuroendocrinol. 2002, 11:853-860.
182. Lawrence C.B., Williams T., Luckman S.M. Intracerebroventricular galanin-like peptide induces different brain activation compared with galanin. Endocrinology 2003, 9:3977-3984.
183. Lecklin A., Lundell I., Salmela S., Mannisto P.T., Beck-Sickinger A.G., Larhammar D. Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs. Br. J. Pharmacol. 2003, 8:1433-1440.
184. Leslie C.P., Bentley J., Biagetti M., Contini S., Di Fabio R., Donati D., Genski T., Guery S., Mazzali A., Merlo G., Pizzi D.A., Sacco F., Seri C., Tessari M., Zonzini L., Caberlotto L. Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists. Bioorg. Med. Chem. Lett. 2010, 20:6103-6107.
185. Levine A.S., Morley J.E. Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 1984, 6:1025-1029.
186. Li A.J., Ritter S. Glucoprivation increases expression of neuropeptide Y mRNA in hindbrain neurons that innervate the hypothalamus. Eur. J. Neurosci. 2004, 8:2147-2154.
187. Li B.H., Xu B., Rowland N.E., Kalra S.P. c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption. Brain Res. 1994, 2:277-284.
188. Li C., Chen P., Smith M.S. The acute suckling stimulus induces expression of neuropeptide Y (NPY) in cells in the dorsomedial hypothalamus and increases NPY expression in the arcuate nucleus. Endocrinology 1998, 4:1645-1652.
189. Li C., Chen P., Smith M.S. Neuropeptide Y (NPY) neurons in the arcuate nucleus (ARH) and dorsomedial nucleus (DMH), areas activated during lactation, project to the paraventricular nucleus of the hypothalamus (PVH). Regul. Pept. 1998, 93-100.
190. Li G., Stamford A.W., Huang Y., Cheng K.C., Cook J., Farley C., Gao J., Ghibaudi L., Greenlee W.J., Guzzi M., van Heek M., Hwa J.J., Kelly J., Mullins D., Parker E.M., Wainhaus S., Zhang X. Discovery of novel orally active ureido NPY Y5 receptor antagonists. Bioorg. Med. Chem. Lett. 2008, 3:1146-1150.
191. Lin E.J., Sainsbury A., Lee N.J., Boey D., Couzens M., Enriquez R., Slack K., Bland R., During M.J., Herzog H. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Endocrinology 2006, 11:5094-5101.
192. Lumb K.J., DeCarr L.B., Milardo L.F., Mays M.R., Buckholz T.M., Fisk S.E., Pellegrino C.M., Ortiz A.A., Mahle C.D. Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice. J. Med. Chem. 2007, 9:2264-2268.
193. Luquet S., Perez F.A., Hnasko T.S., Palmiter R.D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005, 5748:683-685.
194. Lutz T.A., Del Prete E., Scharrer E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol. Behav. 1994, 5:891-895.
195. Lutz T.A., Rossi R., Althaus J., Del Prete E., Scharrer E. Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats. Peptides 1998, 9:1533-1540.
196. Majdic G., Young M., Gomez-Sanchez E., Anderson P., Szczepaniak L.S., Dobbins R.L., McGarry J.D., Parker K.L. Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 2002, 2:607-614.
197. Man P.S., Lawrence C.B. The effects of galanin-like peptide on energy balance, body temperature and brain activity in the mouse and rat are independent of the GALR2/3 receptor. J. Neuroendocrinol. 2008, 1:128-137.
198. Marin Bivens C.L., Thomas W.J., Stanley B.G. Similar feeding patterns are induced by perifornical neuropeptide Y injection and by food deprivation. Brain Res. 1998, 1-2:271-280.
199. Marsh D.J., Hollopeter G., Kafer K.E., Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat. Med. 1998, 6:718-721.
200. Matsumoto Y., Watanabe T., Adachi Y., Itoh T., Ohtaki T., Onda H., Kurokawa T., Nishimura O., Fujino M. Galanin-like peptide stimulates food intake in the rat. Neurosci. Lett. 2002, 1:67-69.
201. McCrea K., Wisialowski T., Cabrele C., Church B., Beck-Sickinger A., Kraegen E., Herzog H. 2-36[K4,RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake. Regul. Pept. 2000, 1-3:47-58.
202. Melander T., Hokfelt T., Rokaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J. Comp. Neurol. 1986, 4:475-517.
203. Melnick I., Pronchuk N., Cowley M.A., Grove K.L., Colmers W.F. Developmental switch in neuropeptide Y and melanocortin effects in the paraventricular nucleus of the hypothalamus. Neuron 2007, 6:1103-1115.
204. Merchenthaler I., Rotoli G., Grignol G., Dudas B. Intimate associations between the neuropeptide Y system and the galanin-immunoreactive neurons in the human diencephalon. Neuroscience 2010, 3:839-845.
205. Michalkiewicz M., Knestaut K.M., Bytchkova E.Y., Michalkiewicz T. Hypotension and reduced catecholamines in neuropeptide Y transgenic rats. Hypertension 2003, 5:1056-1062.
206. Michalkiewicz M., Michalkiewicz T. Developing transgenic neuropeptide Y rats. Methods Mol. Biol. 2000, 73-89.
207. Mikkelsen J.D., Larsen P.J. A high concentration of NPY (Y1)-receptor mRNA-expressing cells in the rat arcuate nucleus. Neurosci. Lett. 1992, 1-2:195-198.
208. Mondal M.S., Date Y., Yamaguchi H., Toshinai K., Tsuruta T., Kangawa K., Nakazato M. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul. Pept. 2005, 1-2:55-59.
209. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 6636:903-908.
210. Moreno G., Perello M., Gaillard R.C., Spinedi E. Orexin a stimulates hypothalamic-pituitary-adrenal (HPA) axis function, but not food intake, in the absence of full hypothalamic NPY-ergic activity. Endocrine 2005, 2:99-106.
211. Morgan D.G., Small C.J., Abusnana S., Turton M., Gunn I., Heath M., Rossi M., Goldstone A.P., O'Shea D., Meeran K., Ghatei M., Smith D.M., Bloom S. The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism. Regul. Pept. 1998, 377-382.
212. Morley J.E., Flood J.F. Amylin decreases food intake in mice. Peptides 1991, 4:865-869.
213. Morris M.J., Nguyen T. Does neuropeptide Y contribute to the anorectic action of amylin?. Peptides 2001, 3:541-546.
214. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature 2006, 7109:289-295.
215. Mounien L., Bizet P., Boutelet I., Vaudry H., Jegou S. Expression of melanocortin MC3 and MC4 receptor mRNAs by neuropeptide Y neurons in the rat arcuate nucleus. Neuroendocrinology 2005, 3-4:164-170.
216. Mullins D., Kirby D., Hwa J., Guzzi M., Rivier J., Parker E. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo. Mol. Pharmacol. 2001, 3:534-540.
217. Muroya S., Funahashi H., Yamanaka A., Kohno D., Uramura K., Nambu T., Shibahara M., Kuramochi M., Takigawa M., Yanagisawa M., Sakurai T., Shioda S., Yada T. Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur. J. Neurosci. 2004, 6:1524-1534.
218. Nakamura M., Sakanaka C., Aoki Y., Ogasawara H., Tsuji T., Kodama H., Matsumoto T., Shimizu T., Noma M. Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. J. Biol. Chem. 1995, 50:30102-30110.
219. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001, 6817:194-198.
220. Naveilhan P., Hassani H., Canals J.M., Ekstrand A.J., Larefalk A., Chhajlani V., Arenas E., Gedda K., Svensson L., Thoren P., Ernfors P., behavior Normal feeding body weight and leptin response require the neuropeptide Y Y2 receptor. Nat. Med. 1999, 10:1188-1193.
221. Naveilhan P., Hassani H., Lucas G., Blakeman K.H., Hao J.X., Xu X.J., Wiesenfeld-Hallin Z., Thoren P., Ernfors P. Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature 2001, 6819:513-517.
222. Nichol K.A., Morey A., Couzens M.H., Shine J., Herzog H., Cunningham A.M. Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control. J. Neurosci. 1999, 23:10295-10304.
223. Norenberg W., Bek M., Limberger N., Takeda K., Illes P. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 4:337-347.
224. Obici S., Feng Z., Karkanias G., Baskin D.G., Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 2002, 6:566-572.
225. O'Hare M.M., Tenmoku S., Aakerlund L., Hilsted L., Johnsen A., Schwartz T.W. Neuropeptide Y in guinea pig, rabbit, rat and man. Identical amino acid sequence and oxidation of methionine-17. Regul. Pept. 1988, 4:293-304.
226. Olszewski P.K., Grace M.K., Billington C.J., Levine A.S. Hypothalamic paraventricular injections of ghrel, effect on feeding and c-Fos immunoreactivity. Peptides 2003, 6:919-923.
227. Olszewski P.K., Li D., Grace M.K., Billington C.J., Kotz C.M., Levine A.S. Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. Peptides 2003, 4:597-602.
228. Ortiz A.A., Milardo L.F., DeCarr L.B., Buckholz T.M., Mays M.R., Claus T.H., Livingston J.N., Mahle C.D., Lumb K.J. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents. J. Pharmacol. Exp. Ther. 2007, 2:692-700.
229. O'Shea D., Morgan D.G., Meeran K., Edwards C.M., Turton M.D., Choi S.J., Heath M.M., Gunn I., Taylor G.M., Howard J.K., Bloom C.I., Small C.J., Haddo O., Ma J.J., Callinan W., Smith D.M., Ghatei M.A., Bloom S.R. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology 1997, 1:196-202.
230. Parker E.M., Balasubramaniam A., Guzzi M., Mullins D.E., Salisbury B.G., Sheriff S., Witten M.B., Hwa J.J. D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake. Peptides 2000, 3:393-399.
231. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 1999, 4:1431-1448.
232. Parrado C., Diaz-Cabiale Z., Garcia-Coronel M., Agnati L.F., Covenas R., Fuxe K., Narvaez J.A. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption. Neuropharmacology 2007, 2:684-692.
233. Patel H.R., Qi Y., Hawkins E.J., Hileman S.M., Elmquist J.K., Imai Y., Ahima R.S. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. Diabetes 2006, 11:3091-3098.
234. Patterson M., Murphy K.G., Thompson E.L., Smith K.L., Meeran K., Ghatei M.A., Bloom S.R. Microinjection of galanin-like peptide into the medial preoptic area stimulates food intake in adult male rats. J. Neuroendocrinol. 2006, 10:742-747.
235. Pedrazzini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., Brunner H.R. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat. Med. 1998, 6:722-726.
236. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 5223:540-543.
237. Pich E.M., Messori B., Zoli M., Ferraguti F., Marrama P., Biagini G., Fuxe K., Agnati L.F. Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats. Brain Res. 1992, 2:265-271.
238. Pittner R.A., Moore C.X., Bhavsar S.P., Gedulin B.R., Smith P.A., Jodka C.M., Parkes D.G., Paterniti J.R., Srivastava V.P., Young A.A. Effects of PYY[3-36] in rodent models of diabetes and obesity. Int. J. Obes. Relat. Metab. Disord. 2004, 8:963-971.
239. Pralong F.P., Gonzales C., Voirol M.J., Palmiter R.D., Brunner H.R., Gaillard R.C., Seydoux J., Pedrazzini T. The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J. 2002, 7:712-714.
240. Pronchuk N., Beck-Sickinger A.G., Colmers W.F. Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology 2002, 2:535-543.
241. Pronchuk N., Colmers W.F. NPY presynaptic actions are reduced in the hypothalamic mpPVN of obese (fa/fa), but not lean, Zucker rats in vitro. Br. J. Pharmacol. 2004, 6:1032-1036.
242. Rodriguez M., Audinot V., Dromaint S., Macia C., Lamamy V., Beauverger P., Rique H., Imbert J., Nicolas J.P., Boutin J.A., Galizzi J.P. Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform. Biochem. J. Pt 2003, 3:667-673.
243. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., Kienzle B., Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 1995, 39:22661-22664.
244. Roseberry A.G., Liu H., Jackson A.C., Cai X., Friedman J.M. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 2004, 5:711-722.
245. Rudolf K., Eberlein W., Engel W., Wieland H.A., Willim K.D., Entzeroth M., Wienen W., Beck-Sickinger A.G., Doods H.N. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur. J. Pharmacol. 1994, 2-3:R11-3.
246. Sahu A., Sninsky C.A., Kalra S.P. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes. Brain Res. 1997, 2:339-342.
247. Sahu A., Sninsky C.A., Phelps C.P., Dube M.G., Kalra P.S., Kalra S.P. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 1992, 6:2979-2985.
248. Sainsbury A., Bergen H.T., Boey D., Bamming D., Cooney G.J., Lin S., Couzens M., Stroth N., Lee N.J., Lindner D., Singewald N., Karl T., Duffy L., Enriquez R., Slack K., Sperk G., Herzog H. Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice. Diabetes 2006, 1:19-26.
249. Sainsbury A., Schwarzer C., Couzens M., Fetissov S., Furtinger S., Jenkins A., Cox H.M., Sperk G., Hokfelt T., Herzog H. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc. Natl. Acad. Sci. USA 2002, 13:8938-8943.
250. Sakamoto T., Moriya M., Tsuge H., Takahashi T., Haga Y., Nonoshita K., Okamoto O., Takahashi H., Sakuraba A., Hirohashi T., Shibata T., Kanno T., Ito J., Iwaasa H., Gomori A., Ishihara A., Fukuroda T., Kanatani A., Fukami T. Novel orally active NPY Y5 receptor antagonists: Synthesis and structure-activity relationship of spiroindoline class compounds. Bioorg. Med. Chem. 2009, 14:5015-5026.
251. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 4:573-585.
252. Salaneck E., Larson E.T., Larsson T.A., Larhammar D. Effects of a teleost tetraploidization on neuropeptide Y receptor gene repertoire in ray-finned fishes. Ann. NY Acad. Sci. 2005, 457-459.
253. Sanacora G., Kershaw M., Finkelstein J.A., White J.D. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 1990, 2:730-737.
254. Santic R., Fenninger K., Graf K., Schneider R., Hauser-Kronberger C., Schilling F.H., Kogner P., Ratschek M., Jones N., Sperl W., Kofler B. Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene. J. Mol. Neurosci. 2006, 2:145-152.
255. Santic R., Schmidhuber S.M., Lang R., Rauch I., Voglas E., Eberhard N., Bauer J.W., Brain S.D., Kofler B. Alarin is a vasoactive peptide. Proc. Natl. Acad. Sci. USA 2007, 24:10217-10222.
256. Sato N., Ando M., Ishikawa S., Jitsuoka M., Nagai K., Takahashi H., Sakuraba A., Tsuge H., Kitazawa H., Iwaasa H., Mashiko S., Gomori A., Moriya R., Fujino N., Ohe T., Ishihara A., Kanatani A., Fukami T. Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effect. J. Med. Chem. 2009, 10:3385-3396.
257. Schwartz M.W., Sipols A.J., Marks J.L., Sanacora G., White J.D., Scheurink A., Kahn S.E., Baskin D.G., Woods S.C., Figlewicz D.P. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 1992, 6:3608-3616.
258. Scott V., Kimura N., Stark J.A., Luckman S.M. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour. J. Neuroendocrinol. 2005, 7:452-457.
259. Segal-Lieberman G., Trombly D.J., Juthani V., Wang X., Maratos-Flier E. NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting. Am. J. Physiol. Endocrinol. Metab. 2003, 6:E1131-9.
260. Seth A., Stanley S., Dhillo W., Murphy K., Ghatei M., Bloom S. Effects of galanin-like peptide on food intake and the hypothalamo-pituitary-thyroid axis. Neuroendocrinology 2003, 2:125-131.
261. Shi Y.C., Lin S., Wong I.P., Baldock P.A., Aljanova A., Enriquez R.F., Castillo L., Mitchell N.F., Ye J.M., Zhang L., Macia L., Yulyaningsih E., Nguyen A.D., Riepler S.J., Herzog H., Sainsbury A. NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice. PLoS One 2010, 6:e11361.
262. Shibasaki T., Oda T., Imaki T., Ling N., Demura H. Injection of anti-neuropeptide Y gamma-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats. Brain Res. 1993, 1-2:313-316.
263. Shionogi & Co., Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, A Novel NPY Y5 Receptor Antagonist being Investigated for the Treatment of Obesity, 2009.
264. Shoblock J.R., Welty N., Nepomuceno D., Lord B., Aluisio L., Fraser I., Motley S.T., Sutton S.W., Morton K., Galici R., Atack J.R., Dvorak L., Swanson D.M., Carruthers N.I., Dvorak C., Lovenberg T.W., Bonaventure P. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor. Psychopharmacology (Berl.) 2010, 2:265-277.
265. Sindelar D.K., Palmiter R.D., Woods S.C., Schwartz M.W. Attenuated feeding responses to circadian and palatability cues in mice lacking neuropeptide Y. Peptides 2005, 12:2597-2602.
266. Sipols A.J., Baskin D.G., Schwartz M.W. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 1995, 2:147-151.
267. Skofitsch G., Jacobowitz D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 1985, 3:509-546.
268. Smith M.S. Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. Endocrinology 1993, 3:1258-1265.
269. Stanley B.G., Chin A.S., Leibowitz S.F. Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action. Brain Res. Bull. 1985, 6:521-524.
270. Stanley B.G., Magdalin W., Seirafi A., Nguyen M.M., Leibowitz S.F. Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Peptides 1992, 3:581-587.
271. Stanley B.G., Magdalin W., Seirafi A., Thomas W.J., Leibowitz S.F. The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res. 1993, 1-2:304-317.
272. Starback P., Wraith A., Eriksson H., Larhammar D. Neuropeptide Y receptor gene y6: multiple deaths or resurrections?. Biochem. Biophys. Res. Commun. 2000, 1:264-269.
273. Statnick M.A., Schober D.A., Gackenheimer S., Johnson D., Beavers L., Mayne N.G., Burnett J.P., Gadski R., Gehlert D.R. Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites. Brain Res. 1998, 1-2:16-26.
274. Ste Marie L., Luquet S., Cole T.B., Palmiter R.D. Modulation of neuropeptide Y expression in adult mice does not affect feeding. Proc. Natl. Acad. Sci. USA 2005, 51:18632-18637.
275. Sternson S.M., Shepherd G.M., Friedman J.M. Topographic mapping of VMH → arcuate nucleus microcircuits and their reorganization by fasting. Nat. Neurosci. 2005, 10:1356-1363.
276. Stricker-Krongrad A., Max J.P., Musse N., Nicolas J.P., Burlet C., Beck B. Increased threshold concentrations of neuropeptide Y for a stimulatory effect on food intake in obese Zucker rats - changes in the microstructure of the feeding behavior. Brain Res. 1994, 1:162-166.
277. Takahashi K.A., Cone R.D. Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y/Agouti-related protein neurons. Endocrinology 2005, 3:1043-1047.
278. Takahashi T., Haga Y., Sakamoto T., Moriya M., Okamoto O., Nonoshita K., Shibata T., Suga T., Takahashi H., Hirohashi T., Sakuraba A., Gomori A., Iwaasa H., Ohe T., Ishihara A., Ishii Y., Kanatani A., Fukami T. Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists. Bioorg. Med. Chem. Lett. 2009, 13:3511-3516.
279. Takatsu Y., Matsumoto H., Ohtaki T., Kumano S., Kitada C., Onda H., Nishimura O., Fujino M. Distribution of galanin-like peptide in the rat brain. Endocrinology 2001, 4:1626-1634.
280. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K.J., Smutko J.S., Mays G.G., Wool E.A., Monroe C.A., Tepper R.I. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 7:1263-1271.
281. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982, 5858:659-660.
282. Tempel D.L., Leibowitz K.J., Leibowitz S.F. Effects of PVN galanin on macronutrient selection. Peptides 1988, 2:309-314.
283. Thiele T.E., Marsh D.J., Ste Marie L., Bernstein I.L., Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 1998, 6709:366-369.
284. Thompson R.H., Swanson L.W. Organization of inputs to the dorsomedial nucleus of the hypothalamus: a reexamination with Fluorogold and PHAL in the rat. Brain Res. Brain Res. Rev. 1998, 2:89-118.
285. Thorpe A.J., Doane D.F., Sweet D.C., Beverly J.L., Kotz C.M. Orexin A in the rostrolateral hypothalamic area induces feeding by modulating GABAergic transmission. Brain Res. 2006, 1:60-66.
286. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., Mathe A.A., Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl. Acad. Sci. USA 2000, 23:12852-12857.
287. Tiesjema B., Adan R.A., Luijendijk M.C., Kalsbeek A., la Fleur S.E. Differential effects of recombinant adeno-associated virus-mediated neuropeptide Y overexpression in the hypothalamic paraventricular nucleus and lateral hypothalamus on feeding behavior. J. Neurosci. 2007, 51:14139-14146.
288. Tiesjema B., la Fleur S.E., Luijendijk M.C., Adan R.A. Sustained NPY overexpression in the PVN results in obesity via temporarily increasing food intake. Obesity 2009, (Silver Spring):1448-1450.
289. Tiesjema B., la Fleur S.E., Luijendijk M.C., Brans M.A., Lin E.J., During M.J., Adan R.A. Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity. Obesity 2007, (Silver Spring 1):2424-2435.
290. Tokita S., Takahashi K., Kotani H. Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders. J. Pharmacol. Sci. 2006, 1:12-18.
291. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., Guan J.L., Wang Q.P., Funahashi H., Sakurai T., Shioda S., Matsukura S., Kangawa K., Nakazato M. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 2003, 4:1506-1512.
292. Tritos N.A., Elmquist J.K., Mastaitis J.W., Flier J.S., Maratos-Flier E. Characterization of expression of hypothalamic appetite-regulating peptides in obese hyperleptinemic brown adipose tissue-deficient (uncoupling protein-promoter-driven diphtheria toxin A) mice. Endocrinology 1998, 11:4634-4641.
293. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 6806:908-913.
294. van den Pol A.N., Acuna-Goycolea C., Clark K.R., Ghosh P.K. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 2004, 4:635-652.
295. van den Pol A.N., Yao Y., Fu L.Y., Foo K., Huang H., Coppari R., Lowell B.B., Broberger C. Neuromedin B and gastrin-releasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong Renilla green fluorescent protein in NPY neurons. J. Neurosci. 2009, 14:4622-4639.
296. van den Top M., Lee K., Whyment A.D., Blanks A.M., Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat. Neurosci. 2004, 5:493-494.
297. Van Der Kolk N., Madison F.N., Mohr M., Eberhard N., Kofler B., Fraley G.S. Alarin stimulates food intake in male rats and LH secretion in castrated male rats. Neuropeptides 2010, 4:333-340.
298. Verty A.N., Boon W.M., Mallet P.E., McGregor I.S., Oldfield B.J. Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). Eur. J. Neurosci. 2009, 11:2207-2216.
299. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 1999, 1:25-30.
300. Vickers S.P., Kennett G.A. Cannabinoids and the regulation of ingestive behaviour. Curr. Drug Targets 2005, 2:215-223.
301. Vrang N., Madsen A.N., Tang-Christensen M., Hansen G., Larsen P.J. PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 2:R367-75.
302. Wahlestedt C., Yanaihara N., Hakanson R. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul. Pept. 1986, 3-4:307-318.
303. Wang C., Yang N., Wu S., Liu L., Sun X., Nie S. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet. Horm. Metab. Res. 2007, 4:262-267.
304. Weinberg D.H., Sirinathsinghji D.J., Tan C.P., Shiao L.L., Morin N., Rigby M.R., Heavens R.H., Rapoport D.R., Bayne M.L., Cascieri M.A., Strader C.D., Linemeyer D.L., MacNeil D.J. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 1996, 28:16435-16438.
305. Wellman P.J. Norepinephrine and the control of food intake. Nutrition 2000, 10:837-842.
306. Wharton J., Gordon L., Byrne J., Herzog H., Selbie L.A., Moore K., Sullivan M.H., Elder M.G., Moscoso G., Taylor K.M. Expression of the human neuropeptide tyrosine Y1 receptor. Proc. Natl. Acad. Sci. USA 1993, 2:687-691.
307. Widdowson P.S. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor. Brain Res. 1997, 1-2:17-25.
308. Widdowson P.S., Upton R., Henderson L., Buckingham R., Wilson S., Williams G. Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat. Brain Res. 1997, 1-2:1-10.
309. Wieland H.A., Engel W., Eberlein W., Rudolf K., Doods H.N. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol. 1998, 3:549-555.
310. Wilding J.P., Gilbey S.G., Bailey C.J., Batt R.A., Williams G., Ghatei M.A., Bloom S.R. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 1993, 5:1939-1944.
311. Willesen M.G., Kristensen P., Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999, 5:306-316.
312. Williams G., Shellard L., Lewis D.E., McKibbin P.E., McCarthy H.D., Koeslag D.G., Russell J.C. Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR:LA corpulent rat. Peptides 1992, 3:537-540.
313. Woods S.C., Lotter E.C., McKay L.D., Porte Jr D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979, 5738:503-505.
314. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 2001, 12:5992.
315. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001, 11:2540-2547.
316. Wyss P., Stricker-Krongrad A., Brunner L., Miller J., Crossthwaite A., Whitebread S., Criscione L. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes. Regul. Pept. 1998, 363-371.
317. Xin X.G., Huang X.F. Down-regulated NPY receptor subtype-5 mRNA expression in genetically obese mouse brain. Neuroreport 1998, 4:737-741.
318. Xu B., Kalra P.S., Moldawer L.L., Kalra S.P. Increased appetite augments hypothalamic NPY Y1 receptor gene expression: effects of anorexigenic ciliary neurotropic factor. Regul. Pept. 1998, 391-395.
319. Yamanaka A., Kunii K., Nambu T., Tsujino N., Sakai A., Matsuzaki I., Miwa Y., Goto K., Sakurai T. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 2000, 2:404-409.
320. Yang L., Scott K.A., Hyun J., Tamashiro K.L., Tray N., Moran T.H., Bi S. Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance. J. Neurosci. 2009, 1:179-190.
321. Zammaretti F., Panzica G., Eva C. Sex-dependent regulation of hypothalamic neuropeptide Y-Y1 receptor gene expression in moderate/high fat, high-energy diet-fed mice. J. Physiol. ***Pt 2007, 2:445-454.
322. Zammaretti F., Panzica G., Eva C. Fasting, leptin treatment, and glucose administration differentially regulate Y(1) receptor gene expression in the hypothalamus of transgenic mice. Endocrinology 2001, 9:3774-3782.
323. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993, 4:1753-1758.
324. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 6505:425-432.